Asthma
COPD
Pulmonary
Pulmonary: Page 20
Lixudebart receives FDA Orphan Drug status
The anti-CLDN1 antibody has been developed to treat IPF.
June 13, 2024
Positive results of new formulation, administration of Rybrevant
Johnson & Johnson demonstrates efficacy in fourth phase 3 clinical trial of the drug therapy.
June 5, 2024
Could bioelectronic medicine be the answer to curing PAH?
A research team at the Feinstein Institutes provides promising results.
June 5, 2024
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
ATS session presents potential discovery for women with PH
Research suggests likely association between hormone replacement therapy and pulmonary hypertension.
May 31, 2024
Hopeful IPF drug falls short in latest trial
Pamrevlumab performs in early phases but fails to slow progression in long term.
May 31, 2024
Revolutionizing imaging software to help save lives
Scientists develop better diagnostic solution for patients with lung conditions who can’t endure contrast dye.
May 28, 2024
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
Imdelltra receives FDA accelerated approval
Novel therapy will treat adult patients with extensive-stage small cell lung cancer.
May 28, 2024
NIH gives grant to advance inhalation therapeutics
Purdue research lab will use funds to develop innovative treatment to fight antimicrobial-resistant lung infections.
May 16, 2024
Behind the scenes of lung cancer transformation
Weill Cornell Medicine researchers catch lung cancer cells in action.
May 16, 2024
Sponsored
Advocate for better air
Ascend Media
The ALA’s State of the Air report provides rankings and recommendations.
July 21, 2026
ALA declares worst air pollution in 25 years
Key highlights and findings from ALA’s 2024 "State of the Air" report.
May 9, 2024
Advancing CF gene therapy
OSU scientists look to improve cystic fibrosis treatment success using mRNA technology.
May 9, 2024
Phoenix scientist proposes new cancer approach
Revolutionary research paves way to transforming pediatric and other cancer treatments.
April 30, 2024
Previous Page
Page 20 of 29
Next Page
Most Popular
Is there a ‘window of opportunity’ for biologic treatment in severe asthma?
FDA approves study of inhaled stem cell therapy for COPD
Common cold: There may be a vaccine for that
Semaglutide significantly lowers asthma, COPD attacks
Novel inhaled treatment for COPD shows promise in clinical trial
Childhood pollution exposure linked to COPD